SEC Form D · filed June 8, 2017
Ralexar Therapeutics, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (16)
Douglas Gessl · Malvern, PAExecNeal Walker · Malvern, PADirectorJason Hong · Menlo Park, CADirectorStephen Tullman · Malvern, PAExec · DirectorDavid Pfeiffer · Malvern, PAExec · DirectorSomu Subramaniam · New York, NYDirectorStephan A. Stein · Uniondale, NYDirectorBenjamin Hom · Los Angeles, CAExec · DirectorSunil K. Gottipati · Princeton, NJExec · DirectorOtlet Capital Management LP · New York, NYDirectorKacy Rozelle · Los Angeles, CAExec · DirectorGregory A. Ellis · New York, NYExec · DirectorStanley R. Westreich · Germantown, MDExec · DirectorI. R. Garr · Germantown, MDExecCraig Kanarick · Brooklyn, NYDirectorChristopher K. Reilly · Greenwich, CTDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗